To ensure supply of the top 3 drugs used to treat COVID-19, it’s time to boost domestic medicine manufacturing
We now know enough about how COVID works for health authorities to have issued clear guidance on which drugs doctors ...
Read moreWe now know enough about how COVID works for health authorities to have issued clear guidance on which drugs doctors ...
Read moreWhile the focus has been largely on vaccines, you might have also heard Pfizer is trialling a pill to treat ...
Read moreThe current demand for Remdesivir drugs is rising in India amid growing cases of COVID-19. Gilead Sciences Inc. makes the ...
Read moreRemdesivir drug receives approval as a treatment medicine for COVID-19 patients. The US Food and Drug Administration (FDA) approves the ...
Read moreI am a physician and a scientist at the University of Virginia. I care for patients and conduct research to ...
Read moreRemdesivir is getting attention once again as Gilead Sciences has announced its price and people are getting mixed reactions about ...
Read moreGilead Sciences is enjoying a boost on its stocks as trial of its possible COVID-19 cure, remdesivir, yields positive result. ...
Read moreAs the world struggles to create a COVID-19 vaccine, some hospitals around the globe are rolling out treatment methods. One ...
Read moreRemdesivir makes its way to Japan this week according to Japanese Health Minister Katsunobu Kato while Japan ships Avigan. Other ...
Read moreIn an effort to combat the coronavirus, Gilead Sciences has decided to donate its entire supply of remdesivir to the ...
Read moreAs a news and media company, our focus is on bringing you the latest news and information from the blockchain, gaming, technology, entertainment, and business industries.
Before reading any material on this website, it is a requirement to read “Terms and Conditions” and “Privacy Policy“ first. By reading or interacting with any of our content, website or social media you agree to be bound by these. This includes, but not limited to the public, consumers, readers & advertisers. Micky is a news site and does not provide trading, investing, or other financial advice. By using this website, you affirm that you have read and agree to abide by our Terms and Conditions